For breast cancer, of the six predicted candidates (PRKCQ, ARAF, MAPK14, BRMS1, CDC42BPA, SP3), three (PRKCQ, ARAF, MAPK14) are members of at least one KEGG cancer relevant pathway. Here, CDC42BPA is linked to breast carcinoma.